OBIO
Orchestra BioMed Holdings, Inc.$3.88-0.22 (-5.37%)Prev Close$4.10·MCap$263.7M·P/E—·Vol151.7K·Yield—
▲
Buys (12M)
8
$163.6K
▼
Sells (12M)
18
$1.15M
◆
Net Activity
Net Seller
$984.1K
●
Active Insiders
11
last 12 mo
Over the past 12 months, insider activity at Orchestra BioMed Holdings, Inc. (OBIO) has been dominated by selling, with 8 insider purchases totaling $163.6K and 18 insider sales totaling $1.15M. The most recent insider transaction was by Hochman David P (director, officer: See Remarks), who purchased $42.9K worth of shares on Mar 16, 2026. Orchestra BioMed Holdings, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $263.7M.
OBIO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Hochman David P | director, officer: See Remarks | Buy | 10,000 | $4.29 | $42.9K | 1,086,467 |
| Feb 5, 2026 | Cleary Chris | Director | Sell | 676 | $3.71 | $2.5K | 0 |
| Jan 2, 2026 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 3,452 | $4.31 | $14.9K | 0 |
| Jan 2, 2026 | Aiello Joshua | Principal Accounting Officer | Sell | 241 | $4.31 | $1.0K | 0 |
| Jan 2, 2026 | Sherman Darren | See Remarks | Sell | 5,588 | $4.31 | $24.1K | 0 |
| Dec 10, 2025 | Hochman David P | See Remarks | Sell | 43,638 | $4.67 | $203.8K | 0 |
| Dec 10, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 8,670 | $4.67 | $40.5K | 0 |
| Nov 25, 2025 | Sherman Darren | See Remarks | Sell | 40,340 | $5.35 | $215.8K | 0 |
| Nov 25, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 3,071 | $5.35 | $16.4K | 0 |
| Nov 14, 2025 | Hochman David P | See Remarks | Buy | 5,000 | $4.07 | $20.4K | 0 |
| Nov 13, 2025 | Hochman David P | See Remarks | Sell | 3,283 | $4.18 | $13.7K | 0 |
| Sep 19, 2025 | Aryeh Jason | Director | Buy | 1,000 | $2.45 | $2.5K | 0 |
| Sep 17, 2025 | Aiello Joshua | Principal Accounting Officer | Sell | 203 | $2.46 | $499.38 | 0 |
| Sep 17, 2025 | Hochman David P | See Remarks | Sell | 43,638 | $2.46 | $107.3K | 0 |
| Sep 17, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 16,102 | $2.46 | $39.6K | 0 |
| Sep 3, 2025 | Sherman Darren | See Remarks | Sell | 40,340 | $2.72 | $109.7K | 0 |
| Aug 25, 2025 | Fain Eric S | Director | Buy | 5,760 | $2.61 | $15.0K | 0 |
| Aug 25, 2025 | Sherman Darren | See Remarks | Buy | 3,000 | $2.62 | $7.9K | 0 |
| Aug 25, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Buy | 2,000 | $2.55 | $5.1K | 0 |
| Aug 21, 2025 | Hochman David P | See Remarks | Buy | 6,000 | $2.49 | $14.9K | 0 |
| Aug 4, 2025 | Hochman David P | See Remarks | Buy | 20,000 | $2.75 | $55.0K | 0 |
| Jun 26, 2025 | Fain Eric S | Director | Sell | 2,683 | $3.05 | $8.2K | 0 |
| Jun 18, 2025 | Aiello Joshua | Principal Accounting Officer | Sell | 393 | $2.99 | $1.2K | 0 |
| Jun 11, 2025 | Hochman David P | See Remarks | Sell | 39,709 | $3.14 | $124.7K | 0 |
| Jun 11, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 28,172 | $3.14 | $88.5K | 0 |
| May 28, 2025 | Sherman Darren | See Remarks | Sell | 45,843 | $2.95 | $135.2K | 0 |
| Mar 26, 2025 | Aiello Joshua | Principal Accounting Officer | Sell | 278 | $4.38 | $1.2K | 0 |
| Mar 7, 2025 | Hochman David P | See Remarks | Sell | 80,080 | $4.23 | $338.7K | 0 |
| Dec 26, 2024 | Hochman David P | See Remarks | Buy | 4,000 | $4.66 | $18.6K | 579,498 |
| Dec 20, 2024 | Taylor Andrew Lawrence | Chief Financial Officer | Buy | 1,000 | $4.83 | $4.8K | 344,960 |
| Dec 19, 2024 | Hochman David P | See Remarks | Buy | 5,000 | $4.91 | $24.6K | 575,498 |
| Sep 26, 2024 | Hochman David P | See Remarks | Buy | 10,000 | $4.79 | $47.9K | 570,498 |
| Sep 10, 2024 | Fain Eric S | Director | Sell | 5,600 | $5.48 | $30.7K | 44,810 |
| Sep 10, 2024 | Sherman Darren | See Remarks | Sell | 13,708 | $5.39 | $73.9K | 772,691 |
| Sep 6, 2024 | Sherman Darren | See Remarks | Sell | 20,617 | $5.87 | $121.0K | 793,275 |
| Aug 15, 2024 | Hochman David P | See Remarks | Buy | 2,500 | $5.84 | $14.6K | 567,998 |
| Jun 26, 2024 | Hochman David P | See Remarks | Buy | 1,000 | $6.95 | $7.0K | 333,502 |
| Jun 3, 2024 | Little William Reed | See Remarks | Buy | 4,000 | $7.00 | $28.0K | 307,859 |
OBIO Insider Buying Activity
The following table shows recent insider purchases of Orchestra BioMed Holdings, Inc. (OBIO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Hochman David P | director, officer: See Remarks | Buy | 10,000 | $4.29 | $42.9K | 1,086,467 |
| Nov 14, 2025 | Hochman David P | See Remarks | Buy | 5,000 | $4.07 | $20.4K | 0 |
| Sep 19, 2025 | Aryeh Jason | Director | Buy | 1,000 | $2.45 | $2.5K | 0 |
| Aug 25, 2025 | Fain Eric S | Director | Buy | 5,760 | $2.61 | $15.0K | 0 |
| Aug 25, 2025 | Sherman Darren | See Remarks | Buy | 3,000 | $2.62 | $7.9K | 0 |
| Aug 25, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Buy | 2,000 | $2.55 | $5.1K | 0 |
| Aug 21, 2025 | Hochman David P | See Remarks | Buy | 6,000 | $2.49 | $14.9K | 0 |
| Aug 4, 2025 | Hochman David P | See Remarks | Buy | 20,000 | $2.75 | $55.0K | 0 |
| Dec 26, 2024 | Hochman David P | See Remarks | Buy | 4,000 | $4.66 | $18.6K | 579,498 |
| Dec 20, 2024 | Taylor Andrew Lawrence | Chief Financial Officer | Buy | 1,000 | $4.83 | $4.8K | 344,960 |
| Dec 19, 2024 | Hochman David P | See Remarks | Buy | 5,000 | $4.91 | $24.6K | 575,498 |
| Sep 26, 2024 | Hochman David P | See Remarks | Buy | 10,000 | $4.79 | $47.9K | 570,498 |
| Aug 15, 2024 | Hochman David P | See Remarks | Buy | 2,500 | $5.84 | $14.6K | 567,998 |
| Jun 26, 2024 | Hochman David P | See Remarks | Buy | 1,000 | $6.95 | $7.0K | 333,502 |
| Jun 3, 2024 | Little William Reed | See Remarks | Buy | 4,000 | $7.00 | $28.0K | 307,859 |
OBIO Insider Selling Activity
The following table shows recent insider sales of Orchestra BioMed Holdings, Inc. (OBIO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | Cleary Chris | Director | Sell | 676 | $3.71 | $2.5K | 0 |
| Jan 2, 2026 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 3,452 | $4.31 | $14.9K | 0 |
| Jan 2, 2026 | Aiello Joshua | Principal Accounting Officer | Sell | 241 | $4.31 | $1.0K | 0 |
| Jan 2, 2026 | Sherman Darren | See Remarks | Sell | 5,588 | $4.31 | $24.1K | 0 |
| Dec 10, 2025 | Hochman David P | See Remarks | Sell | 43,638 | $4.67 | $203.8K | 0 |
| Dec 10, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 8,670 | $4.67 | $40.5K | 0 |
| Nov 25, 2025 | Sherman Darren | See Remarks | Sell | 40,340 | $5.35 | $215.8K | 0 |
| Nov 25, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 3,071 | $5.35 | $16.4K | 0 |
| Nov 13, 2025 | Hochman David P | See Remarks | Sell | 3,283 | $4.18 | $13.7K | 0 |
| Sep 17, 2025 | Aiello Joshua | Principal Accounting Officer | Sell | 203 | $2.46 | $499.38 | 0 |
| Sep 17, 2025 | Hochman David P | See Remarks | Sell | 43,638 | $2.46 | $107.3K | 0 |
| Sep 17, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 16,102 | $2.46 | $39.6K | 0 |
| Sep 3, 2025 | Sherman Darren | See Remarks | Sell | 40,340 | $2.72 | $109.7K | 0 |
| Jun 26, 2025 | Fain Eric S | Director | Sell | 2,683 | $3.05 | $8.2K | 0 |
| Jun 18, 2025 | Aiello Joshua | Principal Accounting Officer | Sell | 393 | $2.99 | $1.2K | 0 |
| Jun 11, 2025 | Hochman David P | See Remarks | Sell | 39,709 | $3.14 | $124.7K | 0 |
| Jun 11, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 28,172 | $3.14 | $88.5K | 0 |
| May 28, 2025 | Sherman Darren | See Remarks | Sell | 45,843 | $2.95 | $135.2K | 0 |
| Mar 26, 2025 | Aiello Joshua | Principal Accounting Officer | Sell | 278 | $4.38 | $1.2K | 0 |
| Mar 7, 2025 | Hochman David P | See Remarks | Sell | 80,080 | $4.23 | $338.7K | 0 |
| Sep 10, 2024 | Fain Eric S | Director | Sell | 5,600 | $5.48 | $30.7K | 44,810 |
| Sep 10, 2024 | Sherman Darren | See Remarks | Sell | 13,708 | $5.39 | $73.9K | 772,691 |
| Sep 6, 2024 | Sherman Darren | See Remarks | Sell | 20,617 | $5.87 | $121.0K | 793,275 |
OBIO Insiders
Similar Stocks to OBIO
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B